Evidence map›Paper›PMID 41463008›Full record

ArticleBiomedicines2025

Xymedon Activates the Immune Response in Breast Cancer Xenografts.

Alfiya Fakrieva, Ivan Raginov, Oxana Bondar, Peresvet Pets, Kirill Kryshen, Ramis Shabaev, Pavel Starokon, Konstantin Balakin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alfiya FakrievaOffice of Technology Leadership, Kazan State Medical University, 420012 Kazan, Russia.ORCID 0000-0003-0474-6638
Ivan RaginovInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.ORCID 0000-0002-5279-2623
Oxana BondarScientific and Educational Center of Pharmaceutics, Kazan Federal University, 420008 Kazan, Russia.ORCID 0000-0001-9856-5664
Peresvet PetsResearch-and-Manufacturing Company "Home of Pharmacy", 188663 Kuzmolovsky, Russia.ORCID 0000-0001-9677-5940
Kirill KryshenResearch-and-Manufacturing Company "Home of Pharmacy", 188663 Kuzmolovsky, Russia.ORCID 0000-0003-1451-7716
Ramis ShabaevDepartment of Emergency and General Surgery Named After Professor A. S. Ermolov, Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, 125993 Moscow, Russia.ORCID 0000-0002-0428-7454
Pavel StarokonDepartment of Surgery with a Course in Oncology and Radiation Diagnostics, Branch of the Federal State Budgetary Educational Institution of Higher Education "S.M. Kirov Military Medical Academy" of the Ministry of Defense of Russia, 107392 Moscow, Russia.ORCID 0000-0002-6512-9361
Konstantin BalakinScientific and Educational Center of Pharmaceutics, Kazan Federal University, 420008 Kazan, Russia.ORCID 0000-0001-7611-0802

Funding

Tatchempharmpreparaty, JSC 20230918-1/0.1.1.55-12/583/23, 0050/NIR
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerimmunomodulationpyrimidine derivativexenograft modelXymedon

Identifiers

PMID41463008
PMCPMC12730596

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.